Figure 5.
Prognostic and immunological implications of TGFBR1 in hepatocellular carcinoma (HCC) patients. (a) Survival analysis of HCC patients according to TGFBR1 expression in The Cancer Genome Atlas Liver Hepatocellular Carcinoma (TCGA_LIHC). (b) Survival analysis of HCC patients according to expression of two miRs (miRs: hsa-miR-101-3p and hsa-miR-490-3p) in TCGA_LIHC. (c) Survival analysis of HCC patients according to expression of TGFBR1 and the two miRs in TCGA_LIHC. (d) Immune cell infiltration according to TGFBR1 expression as identified with TIMER analysis. (e) Correlation analysis of TGFBR1 expression with the Treg, M2, and MDSC cell markers in TCGA_LIHC. * p < 0.05; ** p < 0.01.